Primo Chemicals Ltd Valuation Shifts to Fair Amid Strong Price Gains

Valuation Metrics and Recent Price Movement

Primo Chemicals, a micro-cap player in the commodity chemicals industry, has seen its share price surge by 19.71% on 8 June 2026, closing at ₹26.36, up from the previous close of ₹22.02. The stock traded within a range of ₹22.63 to ₹26.42 during the day, approaching its 52-week high of ₹31.44. This price appreciation has coincided with a reclassification of its valuation grade from attractive to fair, reflecting a recalibration of market expectations.

The company’s current P/E ratio stands at 41.07, a level that is elevated compared to many peers but still below some of the very expensive stocks in the sector. For context, Stallion India trades at a P/E of 50.05, Sanstar at 62.77, and Titan Biotech at 61.16, all classified as very expensive. Conversely, Gulshan Polyols, rated attractive, has a P/E of 29.4, while TGV Sraac, considered very attractive, trades at a much lower P/E of 8.81.

Primo Chemicals’ price-to-book value ratio is 1.57, which is moderate within the sector spectrum. This suggests that while the stock is no longer undervalued on a book basis, it has not yet reached the premium territory that some peers occupy. The EV to EBITDA multiple of 11.22 further supports a fair valuation stance, especially when compared to Stallion India’s 30.99 and Sanstar’s 53.68, indicating that Primo remains relatively reasonable on an enterprise value basis.

Comparative Analysis with Peers

When analysing Primo Chemicals alongside its competitors, it is evident that the stock’s valuation is more balanced than many in the commodity chemicals sector. For example, I G Petrochems, with an astronomical P/E of 611.04, is categorised as very expensive, signalling stretched valuations that may not be sustainable. On the other hand, companies like Platinum Industrials and Amines & Plastics, with P/E ratios of 22.71 and 30.02 respectively, also fall into the fair to expensive categories.

Primo’s PEG ratio of 0.12 is particularly noteworthy. This low PEG suggests that the stock’s price growth relative to earnings growth is modest, potentially indicating undervaluation on a growth-adjusted basis. This contrasts with Platinum Industrials’ PEG of 3.43 and Indo Borax & Chemicals’ extremely high PEG of 27.52, which may imply overvaluation relative to growth prospects.

Financial Performance and Returns Contextualised

Despite the valuation shift, Primo Chemicals’ financial performance metrics remain modest. The company’s latest return on capital employed (ROCE) is 2.95%, and return on equity (ROE) is 3.83%, both relatively low and indicative of limited profitability and capital efficiency. These figures may partly justify the cautious market stance reflected in the fair valuation grade.

However, the stock’s recent returns have outpaced the broader market significantly. Year-to-date, Primo Chemicals has delivered a 10.06% return, while the Sensex has declined by 12.88%. Over one month, the stock gained 3.45% against a 3.60% fall in the Sensex, and over one week, it surged 13.92% compared to a 0.71% decline in the benchmark index. Even over a 10-year horizon, Primo Chemicals has delivered an extraordinary 819.11% return, dwarfing the Sensex’s 176.58% gain, underscoring its long-term growth potential despite recent volatility.

Valuation Grade Upgrade and Market Sentiment

On 5 June 2026, MarketsMOJO upgraded Primo Chemicals’ mojo grade from Sell to Hold, reflecting improved investor sentiment and a more balanced risk-reward profile. The mojo score now stands at 61.0, signalling a neutral stance that suggests neither strong buy nor sell conviction. This upgrade aligns with the valuation grade moving from attractive to fair, indicating that while the stock is no longer a bargain, it remains a viable holding for investors seeking exposure to the commodity chemicals sector.

The micro-cap status of Primo Chemicals also implies higher volatility and risk compared to larger peers, which investors should factor into their decision-making. The recent price rally and valuation adjustment may reflect a re-rating based on anticipated earnings growth or sector tailwinds, but the relatively low profitability metrics counsel caution.

Implications for Investors

Investors analysing Primo Chemicals must weigh the recent valuation shift carefully. The move from attractive to fair valuation suggests that much of the positive sentiment and expected growth may already be priced in. The elevated P/E ratio of 41.07, while lower than some peers, is still high relative to the company’s modest ROCE and ROE, signalling that earnings quality and capital efficiency remain areas of concern.

Nonetheless, the stock’s strong relative returns versus the Sensex over multiple time frames highlight its potential as a growth-oriented investment. The low PEG ratio further indicates that the stock’s price appreciation has not outpaced earnings growth excessively, which may appeal to investors seeking growth at a reasonable price.

Given the micro-cap classification and the inherent volatility in the commodity chemicals sector, a Hold rating appears prudent. Investors should monitor quarterly earnings closely, watch for improvements in profitability metrics, and remain alert to sector dynamics that could impact valuation multiples.

Comparing Primo Chemicals with peers reveals that while it is no longer the cheapest option, it remains competitively valued within a sector where many stocks trade at stretched multiples. This relative valuation positioning may provide some downside protection in volatile markets.

Conclusion

Primo Chemicals Ltd’s recent price rally and valuation grade upgrade to fair reflect a market reassessment of its prospects amid a challenging commodity chemicals landscape. While the stock’s P/E and P/BV ratios have risen, they remain moderate compared to several very expensive peers. The company’s low profitability metrics and micro-cap status warrant a cautious approach, but its strong relative returns and reasonable PEG ratio offer a balanced investment case.

Investors should consider Primo Chemicals as a Hold, recognising the fair valuation and potential for steady growth, while remaining vigilant to sector risks and company-specific performance. The upgrade in mojo grade from Sell to Hold by MarketsMOJO underscores this balanced outlook, signalling neither an urgent buy nor a sell recommendation at current levels.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today